Quantbot Technologies LP Amphastar Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$38.65 - $43.48 $57,279 - $64,437	1,482 Added 13.54%	12,430 $497,000
Q1 2024 May 06, 2024	BUY	$42.85 - $63.45 $469,121 - $694,650	10,948 New	10,948 $480,000
Q2 2022 Aug 09, 2022	SELL	$29.79 - $42.29 $17,874 - $25,374	-600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $13,776 - $21,870	600 New	600 $21,000
Q2 2021 Aug 12, 2021	SELL	$17.11 - $20.92 $49,619 - $60,668	-2,900 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$17.21 - $20.65 $44,746 - $53,689	2,600 Added 866.67%	2,900 $53,000
Q4 2020 Feb 12, 2021	BUY	$17.76 - $21.24 $5,328 - $6,371	300 New	300 $6,000
Q4 2019 Feb 10, 2020	SELL	$17.07 - $20.64 $76,815 - $92,880	-4,500 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$19.12 - $22.62 $24,856 - $29,406	-1,300 Reduced 22.41%	4,500 $89,000
Q2 2019 Aug 13, 2019	BUY	$18.92 - $22.96 $109,736 - $133,168	5,800 New	5,800 $122,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.